| Product Name | Unicondyle Knee Prosthesis |
| Classification | Class III |
| Review Division | Center for Medical Device Evaluation of NMPA |
| Applicant Name | Beijing Chunlizhengda Medical Instruments Co., Ltd. |
| Registration Pathway | Domestic Device Innovation Pathway |
| Product Description | The unicondyle knee prosthesis consists of femoral condyle and assembled tibial platform which is composed of tibial platform pad and tibial platform support. The femoral condyle and tibial platform support are made of cast cobalt chromium molybdenum alloy material in accordance with YY 0117.3 standard, the tibial platform pad is made of type 2 ultra-high molecular weight polyethylene material in accordance with GB / T 19701.2 standard, and the developing needle in the tibial platform pad is made of TC4 titanium alloy material in accordance with GB / T 13810 standard. The product is sterilized by irradiation with a period of validity of 5 years. |
| Indications for Use | This product can be used in combination with bone cement for replacement of unilateral condyle of knee joint. |
| Summary of Non-Clinical Testing | The applicant submitted the following non-clinical research materials: • Product performance research • Biocompatibility • Sterilization • Product shelf-life and packaging Contact us to learn more about how to prepare the non-clinical study of this type of product |
| Summary of Clinical Evaluation | • Clinical pathway: CER pathway The registrant submitted the clinical evaluation data in accordance with the requirements of the Technical Guidelines for Clinical Evaluation of Medical Devices, proving that the to-be-registered product is basically the same as the medical devices of the predicate. For the dissimilarities, the equivalent supporting data of mechanical property ratio is submitted to prove that the dissimilarities do not affect the clinical safety and efficacy. Contact us to learn more about the clinical evaluation of this type of product |
| Product Risk/Benefit Analysis | The registrant shall conduct risk analysis on the product according to YY / T 0316-2016 Application of Medical Device Risk Management to Medical Devices. Risk control measures have been taken for the currently known and predictable risks. Through comprehensive evaluation, it is considered that the benefits brought by the listing of the product outweigh the risks at the current cognitive level. In order to ensure the safety of machinery, the following information shall be prompted in the IFU: • Warnings and precautions • Contraindications • Others Contact us to learn more about the risk/benefit analysis of this type of product |
Strategy Consulting
- Market Entry Strategy
- Regulatory Strategy
- Clinical Strategy
- China Localization Strategy
- Hainan Urgent Use Pathway
- Innovation Pathway
- Fast Track Pathway
- Digital Health Consulting
Registration Affairs
- Pre-market Registration
- Modification Registration
- Renewal Registration
- Request for Classification
- Legal Agent Representation
- NMPA Expert Panel Meeting
- NMPA Supplemental Notice
Quality Assurance
- Postmarket Surveillance Compliance (IFU, Label, GSP)
- Adverse Event Reporting
- Recall Handling
- Periodic Risk Evaluation Report
- Annual QMS Self-Inspection Report
- NMPA Inspections & Mock-Audit
- QMS Establishment/Audit/Remediation
- QA Gap Analysis
- Factory Audit
- Unique Device Identifier
Device Testing
- China Local Type Testing
- Device Modification Compliance Testing
- Biocompatibility Testing
- EMC Testing
Clinical Research Organization (CRO)
- Clinical Trials/Research
- Real-World Study
- China CER & MDR CER
- Clinical Evaluation Feasibility Assessment
Customized Training
- China Regulatory Training
- China QMS Training
- China GCP Training
- China Localization Training
- Periodic Regulatory Updates Training
Other Services
- Translation
- Patent & Trademark
- Distributor Evaluation & Audit
- KOL Interview/Consultation
- Investment
- Global regulatory services
